Floatz logo

Oxcarbamezapine

Drug Resistant Epilepsy

Dr Cipto Mangunkusumo General HospitalPhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
89/ 100

Competitive context

11 Active assets in the Drug Resistant Epilepsy cohort.

Asset / SponsorPhaseRating
VITAMIN D
DINA KEUMALA SARI
Phase 3BB
Carbamazepine
Dr Cipto Mangunkusumo General Hospital
Phase 4BB
LAMOTRIGINE
Dr Cipto Mangunkusumo General Hospital
Phase 4BB
Valproic Acid
Dr Cipto Mangunkusumo General Hospital
Phase 4BB
Clobazam
Dr Cipto Mangunkusumo General Hospital
Phase 4B

View all 16 →

Same molecule, other indications

Oxcarbamezapine is also rated in:

focal epilepsyDormant
A
Indicative ·
80 / 100
View asset →
epilepsyDormant
BB
Indicative ·
69 / 100
View asset →
trigeminal neuralgiaDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →